TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹1,192 Cr | ₹1,604 Cr | ₹2,496 Cr | ₹2,123 Cr | ₹2,941 Cr |
What is the latest Secured Loans ratio of TORRENT PHARMACEUTICALS ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹1,192 Cr |
| Mar2024 | ₹1,604 Cr |
| Mar2023 | ₹2,496 Cr |
| Mar2022 | ₹2,123 Cr |
| Mar2021 | ₹2,941 Cr |
How is Secured Loans of TORRENT PHARMACEUTICALS Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,192 Cr | -25.69 | |
| Mar2024 | ₹1,604 Cr | -35.75 | |
| Mar2023 | ₹2,496 Cr | 17.57 | |
| Mar2022 | ₹2,123 Cr | -27.81 | |
| Mar2021 | ₹2,941 Cr | - | |
Compare Secured Loans of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹128,350.0 Cr | -0.2% | -0.9% | 12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,581.0 Cr | -1.8% | 4.1% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,051.0 Cr | -2.8% | -3.7% | 2.6% | Stock Analytics | |
| CIPLA | ₹120,289.0 Cr | -2.1% | -1.7% | 0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,421.0 Cr | -2% | 3.3% | -0.6% | Stock Analytics | |
| MANKIND PHARMA | ₹88,649.9 Cr | -2.8% | -3.3% | -15.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0.2% |
-0.9% |
12.9% |
| SENSEX | -0.8% |
1% |
3.2% |
You may also like the below Video Courses